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Program Evaluation and Data Collection
Through well-planned health promotion and education
programming, federally funded projects are often leaders
in the development and implementation of sound public
health practices. In public health practice, program evalu-
ations are used to 1) determine whether program objec-
tives related to health status have been achieved, 2)
improve program implementation, 3) increase community
support, 4) contribute to a scientific base, 5) provide
accountability to community members and other stake-
holders, and 6) guide program-specific policy decisions
(1,2). To monitor program processes and obtain the evi-
dence necessary to demonstrate a program’s effectiveness,
some form of evaluation involving data collection is usual-
ly completed (3). Evaluation is considered a key component
of public health programming (2,4).
Evaluation methodologies vary significantly among pro-
grams, as do data-collection techniques. In some evalua-
tions, it is appropriate to use previously collected data that
were not originally intended for measuring a program’s
processes and outcomes. For instance, mortality or disease
rates from county vital records or reportable disease
records of state health departments can be used to guide
certain health promotion programming decisions.
However, generally, comprehensive program evaluations
involve planned process measures to gauge completeness
and quality of activities leading to outcomes in addition to
less formal process measures that come about as adjust-
ments to health promotion programming. More formal
evaluation measures are characterized as systematic; they
have long-term outcome indicator measurements that are
planned before the program implementation (2-5).
The Paperwork Reduction Act (PRA)
Evaluations of public health programs are often con-
ducted at taxpayers’ expense because federal agencies are
accountable for the quantity and quality of the informa-
tion resulting from these evaluations. The U.S. public
deserves this, and the U.S. Congress demands it (6).
However, in response to constituent complaints about
unnecessary and often redundant data collections,
Congress passed the Paperwork Reduction Act (PRA) in
1980 to help balance the public demand for accountability
and the resulting paperwork burden on the public (7). The
law was created to “. . . ensure that federal agencies do not
overburden the public with federally sponsored data col-
lections,” with burden being defined as “. . . the total time,
effort, or financial resources expended by persons to gen-
erate, maintain, retain, or disclose or provide information”
(6). In 1995, more reductions were proposed, and the PRA
was amended. Congress mandated a 25% reduction in
burden in the 3 years immediately following the amend-
ment’s passage (8,9).
Compliance with the PRA is required whenever a feder-
al agency sponsors a data collection by using identical
questions, using identical reporting or record-keeping
requirements, or asking respondents to provide the same
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level of information on the same subject involving 10 or
more respondents in a 12-month period (7,10). The law
applies to all federal employees, contractors, people in
cooperative agreements, and anyone else who asks the
public for information for the purpose of research, public
health practice, program evaluation, or any other reason.
The PRA also addresses customer satisfaction invento-
ries, focus group inquiries, all types of surveys, telephone
interviews, and electronic environments. One notable
exception to the PRA is that federal employees may be
solicited for information if the solicitation is in their line
of work and provides information that is relevant to their
work experience (10).
Office of Management and Budget (OMB)
Clearance
When the information gathering intended for evaluation
meets the parameters specified in the PRA, the federal
agency sponsoring the data collection applies for review
and approval before the data collection begins. The U.S.
Office of Management and Budget (OMB) oversees all
requests for review and approval under the PRA (10). The
agency sponsoring the data collection must submit an
OMB clearance package explaining and justifying the data
collection. In addition, two notices with subsequent 30- and
60-day comment periods must be published in the 
Federal Register, a daily U.S. government publication of
the National Archives and Records Administration. OMB
clearance typically takes 6 to 9 months (10). However,
some OMB clearance processes take more than 12 months,
partially because of the overwhelming number of submis-
sions and limited number of staff members (9). To com-
pensate for the PRA requirements and time required to
obtain OMB clearance, evaluation plans should begin
months before data collection begins.
Although the time involved in obtaining OMB clear-
ance can pose a considerable challenge to evaluators,
the process can also significantly improve the quality
of the data collection. Program planners and evalua-
tors should work together to focus their efforts and use
ethical data-collection methods to obtain useful and
necessary data. Such cooperation improves the pro-
gram results while decreasing the public’s burden.
During the clearance process, OMB requires detailed
descriptions of the following (10):
1. The reasons the data collection is necessary
2. The purpose and use of the information that will be
obtained from the data collection
3. The use of improved information technology to reduce
burden
4. Efforts to identify the duplication and use of similar
information
5. The possible impact of the data collection on small
businesses or other small entities (e.g., other people or
groups)
6. The consequences of collecting the data less frequently
than planned
7. Special circumstances relating to Title 5, Part 1320.5
(“Controlling Paperwork Burdens on the Public”) of
the Code of Federal Regulations (CFR) guidelines
about federal information collections
8. Comments in response to the Federal Register
notice and evidence of efforts to consult with indi-
viduals other than those in the agency collecting
the information
9. An explanation of any payments or gifts to respondents
10. Confidentiality assurances provided to respondents
11. Justification for sensitive questions
12. An estimate of annualized cost and burden hours
13. Annualized government costs
14. An explanation for any program changes or adjust-
ments
15. A plan for tabulation and publication and a time
schedule
16. Any reasons that an OMB expiration date might be
inappropriate to post on instrumentation (i.e., all PRA
surveys and materials)
17. Exceptions to certification for the PRA submission
Conclusion
Careful attention to the requirements for OMB clear-
ance enhances program efficiency and improves evalu-
ation processes and outcomes. The requirements are
consistent with academic and professional recommen-
dations that program planning be carried out with
evaluation in mind; the two processes need to be simul-
taneous for best results (3,11).
The general public recognizes that the OMB review and
approval process is a positive procedure that holds the fed-
eral government accountable for the public’s burden to
provide data. Federal agencies that are striving to provide
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OMB compliance to be a difficult but necessary obstacle to
overcome. The PRA, which is enforced by the OMB, is a
reasonable compromise between reducing paperwork bur-
dens on the public and maximizing the benefits of data col-
lection to ensure that well-planned public health programs
have meaningful evaluations. Knowledge about and com-
pliance with the PRA requirements are the essential com-
ponent of the compromise, improving taxpayer satisfaction
and government accountability. Fortunately, all necessary
information about the PRA and OMB is available online
from www.whitehouse.gov/omb/inforeg/infocoll.html,
which guides program planners and evaluators through
the process.
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